Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Shareholders Equity (Quarterly) : -208.00M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -208.00M |
| March 31, 2026 | -144.00M |
| December 31, 2025 | -98.00M |
| September 30, 2025 | -207.00M |
| June 30, 2025 | -257.00M |
| March 31, 2025 | -285.00M |
| December 31, 2024 | -337.00M |
| September 30, 2024 | -167.00M |
| June 30, 2024 | -121.00M |
| March 31, 2024 | 10.00M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -24.00M |
| June 30, 2023 | 117.00M |
| March 31, 2023 | 72.00M |
| December 31, 2022 | 51.00M |
| September 30, 2022 | 227.00M |
| June 30, 2022 | 230.00M |
| March 31, 2022 | 232.00M |
| December 31, 2021 | 203.00M |
| September 30, 2021 | 161.00M |
| June 30, 2021 | 233.00M |
| March 31, 2021 | 164.00M |
| December 31, 2020 | 82.00M |
| Date | Value |
|---|---|
| September 30, 2020 | 80.00M |
| June 30, 2020 | 58.00M |
| March 31, 2020 | 39.00M |
| December 31, 2019 | 209.00M |
| September 30, 2019 | 252.00M |
| June 30, 2019 | 205.00M |
| March 31, 2019 | 133.00M |
| December 31, 2018 | 66.00M |
| September 30, 2018 | 48.00M |
| June 30, 2018 | -43.00M |
| March 31, 2018 | -101.00M |
| December 31, 2017 | -203.00M |
| September 30, 2017 | -74.00M |
| June 30, 2017 | -133.00M |
| March 31, 2017 | -211.00M |
| December 31, 2016 | -295.00M |
| September 30, 2016 | -382.00M |
| June 30, 2016 | -167.00M |
| March 31, 2016 | -230.00M |
| December 31, 2015 | -279.00M |
| September 30, 2015 | -289.00M |
| June 30, 2015 | -334.00M |
| March 31, 2015 | -408.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 1.031B |
| Liquidia Corp. | 195.11M |
| Corcept Therapeutics, Inc. | 705.78M |
| Amneal Pharmaceuticals, Inc. | 33.02M |
| Prestige Consumer Healthcare, Inc. | 1.917B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Total Liabilities (Quarterly) | 1.441B |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 0.8353 |
| Net Debt Paydown Yield | -0.57% |